acebutolol has been researched along with Anemia in 65 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (4.62) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (6.15) | 29.6817 |
| 2010's | 37 (56.92) | 24.3611 |
| 2020's | 21 (32.31) | 2.80 |
| Authors | Studies |
|---|---|
| Blackman, N; Boccia, R; Gilreath, JA; Henry, DH; Krupa, A; Makharadze, T | 1 |
| Bisbe, E; Carol-Boeris, F; García-Erce, JA; Laso-Morales, MJ; Martínez-López, F; Muñoz, M; Pontes-García, C; Vives, R | 1 |
| Ataíde, R; Biselele, K; Braat, S; Chinkhumba, J; Harding, R; Larson, L; Moya, E; Mwangi, MN; Mzembe, G; Pasricha, SR; Phiri, KS; Robberstad, B; Rogerson, S; Simpson, J; Stones, W | 1 |
| Barber, VS; Chester-Jones, M; Drakesmith, H; Dutton, SJ; Frise, MC; Griffith, DM; James, T; Marian, IR; McKechnie, SR; Robbins, PA; Shah, A; Singleton, J; Stanworth, SJ; Walsh, TS; Wray, K; Young, JD | 1 |
| Altuntaş, F; Bozan, E; Çakar, MK; Candır, BA; Dal, MS; İskender, D; Seçilmiş, S; Ulu, BU; Yaman, S; Yiğenoğlu, TN | 1 |
| Fuyuno, Y; Harada, A; Matsuno, Y; Morisaki, S; Saiki, T; Suekane, H; Suzuki, T; Taniguchi, Y; Torisu, T; Umeno, J | 1 |
| Amstad, G; Geiger, J; Heinzelmann, V; Montavon, C; Werlen, L | 1 |
| Campos Fernandes, A; Costa, E; Lucas, J; Robalo Nunes, A; Sequeira, R; Sousa, P; Subtil, A | 1 |
| Aliu, A; Bertrams Maartens, IA; Bevers, N; Escher, H; Oudshoorn, A; Pierik, MJ; Raijmakers, M; Rezazadeh Ardabili, A; Rosias, P; Stapelbroek, J; Teklenburg, S; van de Feen, C; Van de Vijver, E; van Rheenen, PF; Vande Velde, S; Vreugdenhil, A; Winkens, B | 1 |
| Dogan, DY; Eveslage, M; Karst, U; Macke, M; Martens, S; Müller, JC; Olivier, RMR; Rauer, M; Schrader, L; Steinbicker, AU; Wagner, NM; Wempe, C; Zarbock, A | 1 |
| Anker, SD; Butler, J; Fabien, V; Farmakis, D; Filippatos, G; Jankowska, EA; Kirwan, BA; Macdougall, IC; Metra, M; Ponikowski, P; Rosano, G; Ruschitzka, F; van der Meer, P; Wächter, S | 1 |
| Bitton-Worms, K; Bolotin, G; Dann, EJ; Friedman, T; Glam, R; Makhoul, M; Tam, DY; Weis, A | 1 |
| Amarelo, A; Capela, A; Coelho, H; Costa, T; Cunha, Â; Custódio, S; Dias, E; Dias, M; Joaquim, A; Leão, I; Macedo, A; Marinho, J; Moreira Pinto, A | 1 |
| Herrera, A; Mateo-Agudo, J; Muñoz, M; Pinilla-Gracia, C | 1 |
| Luan-Erfe, BM; Sweitzer, B; Yilmaz, M | 1 |
| Jang, JH; Jung, CW; Kim, K; Kim, SJ; Kim, WS; Kim, Y; Lee, J; Lee, SH; Park, S | 1 |
| Hengartner, H; Mattiello, V; Renella, R; Schmugge, M; von der Weid, N | 1 |
| Buyuk, GN; Engin-Ustun, Y; Keskin, HL; Kilickiran, H; Oskovi-Kaplan, ZA; Ozyer, S | 1 |
| Beverina, I; Brando, B; Scalvini, R | 1 |
| Auerbach, M; Farmer, SL; Frank, SM; Hardy, JF; Javidroozi, M; Leahy, MF; Meier, J; Ozawa, S; Shander, A | 1 |
| Allinovi, M; Bagalà, A; Ballo, P; Bellelli, S; Cirillo, L; Dallari, LA; Dattolo, PC; Di Marcantonio, E; Ferro, G; Somma, C | 1 |
| Andrès, A; Assouline, B; Benoliel, A; Delhumeau, C; Favre, M; Legouis, D; Samii, K; Schiffer, E; Toso, C; Zamberg, I | 1 |
| Auerbach, M; Macdougall, I | 1 |
| Hubert, L; Lasocki, S; Rineau, E; Samson, E; Stoyanov, A | 1 |
| An, JY; Bae, JM; Choi, MG; Eom, BW; Han, M; Jeong, O; Jung, MR; Kim, BS; Kim, HI; Kim, S; Kim, Y; Kim, YW; Kwon, OK; Lee, HJ; Lee, IS; Lee, JH; Nam, BH; Noh, SH; Park, YK; Ryu, KW; Ryu, SY; Sohn, TS; Suh, YS; Yang, H; Yang, HK; Yoo, MW; Yook, JH; Yoon, HM; Yu, W | 1 |
| Boccia, S; Canarecci, S; Ciancarella, G; Collamati, A; de Waure, C; Gasbarrini, A; Kheiraoui, F; Milovanovic, S; Poscia, A; Scaldaferri, F; Schiavoni, E | 1 |
| Li, T; Yu, Z | 1 |
| Kim, YW; Yang, H | 1 |
| Ballester-Clau, R; Cucala-Ramos, M; López-Barroso, L; Planella de Rubinat, M; Reñé-Espinet, JM; Torres Vicente, G; Voltà-Pardo, T | 1 |
| Caló, N; Laso-Morales, MJ; Pontes, C; Valle-Beltran, A; Vallejo-Tarrat, A; Vives, R | 1 |
| Bajor, A; Befrits, R; Blom, H; Blomquist, L; Hammarlund, P; Hjortswang, H; Klintman, D; Wikman, O | 1 |
| Bae, JM; Kim, MJ; Kim, YW; Nam, BH; Park, YK; Reim, D; Roh, SH; Yook, JH; Yu, WS | 1 |
| Arroyo, R; Bisbe, E; Moltó, L; Muniesa, JM; Tejero, M | 1 |
| Acheson, AG; Brookes, MJ; Iqbal, T; Keeler, BD; Ng, S; Simpson, JA; Tselepis, C | 1 |
| Birgegård, G; Felder, M; Hedenus, M; Karlsson, T; Ludwig, H; Roubert, B; Rzychon, B | 1 |
| Baker, S; Erber, W; Farmer, S; Ferrier, J; French, C; Hawkins, D; Higgins, AM; Hofmann, A; Keulenaer, BL; Litton, E; McMorrow, J; Olynyk, J; Richards, T; Towler, S; Webb, S | 1 |
| Ghio, AJ | 1 |
| Anker, SD; Clevenger, B; Collier, T; Keidan, J; Kelly, JD; Klein, AA; Richards, T | 1 |
| Brunetta, DM; De Santis, GC; Garcia, JH; Kaufman, J; Mesquita, DF; Souza, FN | 1 |
| Calleja, JL; Cucala, M; del Val, A; Delgado, S; Hervás, A; Larraona, JL; Mearin, F; Terán, Á | 1 |
| Bizot, P; Chassier, C; Chaudet, A; Lasocki, S; Rineau, E | 1 |
| Anker, SD; Comin-Colet, J; Cooper, TJ; Dickstein, K; Filippatos, G; Johnson, P; Lainscak, M; Lüscher, TF; Mori, C; Ponikowski, P | 1 |
| Acornley, A; Alexander, D; Frew, N; Hood, J | 1 |
| Aparicio, R; Bernabeu-Wittel, M; Melero-Bascones, M; Monte-Secades, R; Murcia-Zaragoza, J; Ollero-Baturone, M; Rincón-Gómez, M; Romero, M; Rosso, CM; Ruiz-Cantero, A | 1 |
| Bäumer, N; Gallitz, I; Kuhlmann, T; Lofruthe, N; Müller-Tidow, C; Schulze, I; Steinbicker, AU; Traeger, L | 1 |
| Auerbach, M; Muñoz, M | 1 |
| Baker, S; De Keulenaer, B; Erber, WN; Farmer, S; Ferrier, J; French, C; Gummer, J; Hawkins, D; Higgins, A; Hofmann, A; Litton, E; McMorrow, J; Olynyk, JK; Richards, T; Towler, S; Trengove, R; Webb, S | 1 |
| Bugat, R; Duvillié, L; Espié, M; Luporsi, E; Perot, S; Pithois Merli, I; Scotté, F; Spaeth, D; Toledano, A | 1 |
| Bakker, SJ; Eisenga, MF; Gaillard, CA | 1 |
| Urato, AC | 1 |
| Cropper, L; Pugh-Clarke, K; Tagboto, S; Turner, J | 1 |
| Bailie, GR | 1 |
| Anker, SD; Jankowska, EA; Ponikowski, P; von Haehling, S | 1 |
| Bisbe, E; Díez-Lobo, AI; García-Erce, JA; Muñoz, M | 1 |
| Bugat, R; de Pouvourville, G; Luporsi, E; Mahi, L; Morre, C; Wernli, J | 1 |
| Doll, D; Ertmer, C; Hagemann, O; Hahnenkamp, K; Hönemann, CW; Kampmeier, T | 1 |
| Aparicio, R; Bernabeu-Wittel, M; Melero-Bascones, M; Monte-Secades, R; Montero, A; Murcia-Zaragoza, J; Romero, M; Rosso, C; Ruiz-Cantero, A | 1 |
| Beaumont, C; Denamur, E; Driss, F; El Benna, J; Heming, N; Lasocki, S; Lettéron, P; Millot, S; Montravers, P; Tourret, J | 1 |
| Javidroozi, M; Shander, A | 1 |
| Christoph, P; De Tejada, BM; Irion, O; Schuller, C; Studer, H; Surbek, D | 1 |
| Halkett, JA; van Zyl-Smit, R | 1 |
| MAZZONI, A | 1 |
| MIYAZAKI, T; SAITO, K; SHINZAKI, R; SHIRAISHI, T; YAMAMOTO, S | 1 |
| Baker, JB; Mangione, A; Martens, MG; Seid, MH; Van Wyck, DB | 1 |
| Sogbanmu, MO | 1 |
2 review(s) available for acebutolol and Anemia
| Article | Year |
|---|---|
The available intravenous iron formulations: History, efficacy, and toxicology.
Topics: Anemia; Drug Compounding; Ferric Compounds; Ferrosoferric Oxide; Humans; Infusions, Intravenous; Iron; Kidney Failure, Chronic; Maltose; Renal Dialysis | 2017 |
Anemia in heart failure: an overview of current concepts.
Topics: Anemia; Comorbidity; Darbepoetin alfa; Erythropoietin; Ferric Compounds; Heart Failure; Hematinics; Humans; Injections, Intravenous; Iron Compounds; Maltose; Prognosis; Risk Assessment; Risk Factors; United States | 2011 |
26 trial(s) available for acebutolol and Anemia
| Article | Year |
|---|---|
Efficacy and safety of ferric carboxymaltose infusion in reducing anemia in patients receiving chemotherapy for nonmyeloid malignancies: A randomized, placebo-controlled study (IRON-CLAD).
Topics: Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Agents; Double-Blind Method; Female; Ferric Compounds; Humans; Induction Chemotherapy; Male; Maltose; Middle Aged; Neoplasms; Placebo Effect; Treatment Outcome | 2021 |
Single-dose intravenous ferric carboxymaltose infusion versus multiple fractionated doses of intravenous iron sucrose in the treatment of post-operative anaemia in colorectal cancer patients: a randomised controlled trial.
Topics: Administration, Intravenous; Anemia; Anemia, Iron-Deficiency; Colorectal Neoplasms; Ferric Compounds; Ferric Oxide, Saccharated; Hemoglobins; Humans; Iron; Maltose | 2022 |
Protocol for a multicentre, parallel-group, open-label randomised controlled trial comparing ferric carboxymaltose with the standard of care in anaemic Malawian pregnant women: the REVAMP trial.
Topics: Anemia; Anemia, Iron-Deficiency; Australia; Female; Ferric Compounds; Humans; Malawi; Maltose; Multicenter Studies as Topic; Pregnancy; Pregnant Women; Randomized Controlled Trials as Topic; Standard of Care | 2021 |
Intravenous iron to treat anaemia following critical care: a multicentre feasibility randomised trial.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anemia; Critical Care; Feasibility Studies; Female; Ferric Compounds; Follow-Up Studies; Hematinics; Hemoglobins; Humans; Length of Stay; Male; Maltose; Middle Aged; Patient Readmission; Patient Reported Outcome Measures; Young Adult | 2022 |
Perioperative management with ferric carboxymaltose and tranexamic acid to reduce transfusion rate in gynaecological carcinoma surgery (TRANAFER-Study): study protocol for a single-blind, monocentre, randomised trial.
Topics: Anemia; Blood Transfusion; Carcinoma; Female; Ferric Compounds; Gynecologic Surgical Procedures; Humans; Iron; Maltose; Randomized Controlled Trials as Topic; Single-Blind Method; Tranexamic Acid | 2022 |
Ferric Carboxymaltose Versus Ferrous Fumarate in Anemic Children with Inflammatory Bowel Disease: The POPEYE Randomized Controlled Clinical Trial.
Topics: Administration, Oral; Anemia; Anemia, Iron-Deficiency; Child; Ferric Compounds; Hemoglobins; Humans; Inflammatory Bowel Diseases; Iron; Maltose; Treatment Outcome | 2023 |
Association Between Hemoglobin Levels and Efficacy of Intravenous Ferric Carboxymaltose in Patients With Acute Heart Failure and Iron Deficiency: An AFFIRM-AHF Subgroup Analysis.
Topics: Anemia; Female; Ferric Compounds; Ferritins; Heart Failure; Hemoglobins; Humans; Iron; Iron Deficiencies; Male; Maltose; Quality of Life; Transferrins; Treatment Outcome | 2023 |
Intravenous iron administration before cardiac surgery reduces red blood cell transfusion in patients without anaemia.
Topics: Administration, Intravenous; Anemia; Cardiac Surgical Procedures; Double-Blind Method; Erythrocyte Transfusion; Ferric Compounds; Hemoglobins; Humans; Iron; Maltose | 2023 |
On the relevance of preoperative haemoglobin optimisation within a Patient Blood Management programme for elective hip arthroplasty surgery.
Topics: Aged; Aged, 80 and over; Anemia; Arthroplasty, Replacement, Hip; Elective Surgical Procedures; Erythrocyte Transfusion; Female; Ferric Compounds; Hemoglobins; Humans; Length of Stay; Male; Maltose; Middle Aged; Retrospective Studies | 2020 |
Efficacy of intravenous iron treatment for chemotherapy-induced anemia: A prospective Phase II pilot clinical trial in South Korea.
Topics: Anemia; Antineoplastic Agents; Biomarkers; Erythropoietin; Female; Ferric Compounds; Hemoglobins; Hepcidins; Humans; Infusions, Intravenous; Male; Maltose; Middle Aged; Neoplasms; Pilot Projects; Republic of Korea; Transferrin; Treatment Outcome | 2020 |
Intravenous iron supplementation after liver surgery: Impact on anemia, iron, and hepcidin levels-a randomized controlled trial.
Topics: Aged; Anemia; C-Reactive Protein; Ferric Compounds; Ferritins; Hepatectomy; Hepcidins; Humans; Infusions, Intravenous; Interleukin-6; Iron; Male; Maltose; Postoperative Care; Postoperative Complications | 2021 |
Effect of Intravenous Ferric Carboxymaltose on Hemoglobin Response Among Patients With Acute Isovolemic Anemia Following Gastrectomy: The FAIRY Randomized Clinical Trial.
Topics: Adult; Aged; Anemia; Female; Ferric Compounds; Gastrectomy; Hematinics; Hemoglobins; Humans; Injections; Male; Maltose; Middle Aged; Postoperative Complications; Single-Blind Method | 2017 |
Single dose of intravenous ferric carboxymaltose infusion versus multiple fractionated doses of intravenous iron sucrose in the treatment of postoperative anaemia in colorectal cancer patients: study protocol for a randomised controlled trial.
Topics: Anemia; Colorectal Neoplasms; Ferric Compounds; Ferric Oxide, Saccharated; Humans; Infusions, Intravenous; Maltose; Postoperative Complications; Randomized Controlled Trials as Topic | 2019 |
FAIRY: a randomized controlled patient-blind phase III study to compare the efficacy and safety of intravenous ferric carboxymaltose (Ferinject®) to placebo in patients with acute isovolemic anemia after gastrectomy - study protocol for a randomized contr
Topics: Anemia; Biomarkers; Blood Volume; Clinical Protocols; Female; Ferric Compounds; Gastrectomy; Hematinics; Hemoglobins; Humans; Infusions, Intravenous; Male; Maltose; Quality of Life; Republic of Korea; Research Design; Stomach Neoplasms; Time Factors; Treatment Outcome | 2014 |
Randomized trial comparing ferric carboxymaltose vs oral ferrous glycine sulphate for postoperative anaemia after total knee arthroplasty.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anemia; Arthroplasty, Replacement, Knee; Female; Ferric Compounds; Ferrous Compounds; Glycine; Humans; Male; Maltose; Middle Aged; Postoperative Complications; Prospective Studies; Single-Blind Method; Spain; Treatment Outcome | 2014 |
The feasibility and clinical efficacy of intravenous iron administration for preoperative anaemia in patients with colorectal cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Anemia; C-Reactive Protein; Colorectal Neoplasms; Erythrocyte Transfusion; Erythropoietin; Feasibility Studies; Female; Ferric Compounds; Hemoglobins; Humans; Infusions, Intravenous; Length of Stay; Male; Maltose; Middle Aged; Pilot Projects; Postoperative Complications; Preoperative Care; Transferrins | 2014 |
Intravenous iron alone resolves anemia in patients with functional iron deficiency and lymphoid malignancies undergoing chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Anemia, Iron-Deficiency; Antineoplastic Agents; Female; Ferric Compounds; Hemoglobins; Humans; Injections, Intravenous; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Male; Maltose; Middle Aged; Multiple Myeloma; Treatment Outcome | 2014 |
The IRONMAN trial: a protocol for a multicentre randomised placebo-controlled trial of intravenous iron in intensive care unit patients with anaemia.
Topics: Anemia; Clinical Protocols; Critical Care; Ferric Compounds; Infusions, Intravenous; Maltose; Research Design | 2014 |
PREVENTT: preoperative intravenous iron to treat anaemia in major surgery: study protocol for a randomised controlled trial.
Topics: Abdomen; Administration, Intravenous; Anemia; Biomarkers; Blood Transfusion; Clinical Protocols; Cost-Benefit Analysis; Double-Blind Method; Drug Costs; England; Ferric Compounds; Health Resources; Hematinics; Hemoglobins; Hospital Costs; Humans; Length of Stay; Maltose; Preoperative Care; Recovery of Function; Research Design; Time Factors; Treatment Outcome | 2015 |
Relation of Longitudinal Changes in Quality of Life Assessments to Changes in Functional Capacity in Patients With Heart Failure With and Without Anemia.
Topics: Aged; Anemia; Exercise Test; Exercise Tolerance; Female; Ferric Compounds; Follow-Up Studies; Heart Failure; Hematinics; Humans; Longitudinal Studies; Male; Maltose; Middle Aged; Quality of Life; Recovery of Function; Self Report; Treatment Outcome | 2016 |
Ferric carboxymaltose with or without erythropoietin in anemic patients with hip fracture: a randomized clinical trial.
Topics: Aged; Aged, 80 and over; Anemia; Double-Blind Method; Erythrocyte Transfusion; Erythropoietin; Female; Ferric Compounds; Hip Fractures; Humans; Male; Maltose; Quality of Life; Treatment Outcome | 2016 |
Intravenous iron or placebo for anaemia in intensive care: the IRONMAN multicentre randomized blinded trial : A randomized trial of IV iron in critical illness.
Topics: Administration, Intravenous; Adult; Aged; Allografts; Anemia; Confidence Intervals; Critical Illness; Double-Blind Method; Erythrocyte Transfusion; Female; Ferric Compounds; Hemoglobins; Humans; Intensive Care Units; Intention to Treat Analysis; Male; Maltose; Middle Aged | 2016 |
The efficacy of a single dose of intravenous ferric carboxymaltose (Ferinject) on anaemia in a pre-dialysis population of chronic kidney disease patients.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Female; Ferric Compounds; Hematinics; Humans; Infusions, Intravenous; Male; Maltose; Middle Aged; Premedication; Renal Dialysis; Renal Insufficiency, Chronic | 2009 |
Ferric carboxymaltose with or without erythropoietin for the prevention of red-cell transfusions in the perioperative period of osteoporotic hip fractures: a randomized contolled trial. The PAHFRAC-01 project.
Topics: Aged; Aged, 80 and over; Anemia; Combined Modality Therapy; Double-Blind Method; Drug Therapy, Combination; Erythrocyte Transfusion; Erythropoietin; Female; Ferric Compounds; Hip Fractures; Humans; Male; Maltose; Osteoporotic Fractures; Postoperative Hemorrhage; Research Design; Treatment Outcome | 2012 |
Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial.
Topics: Administration, Oral; Adult; Anemia; Dietary Supplements; Drug Administration Schedule; Female; Ferric Compounds; Ferrous Compounds; Hematinics; Hemoglobins; Humans; Injections, Intravenous; Maltose; Mexico; Postpartum Period; Pregnancy; United States | 2007 |
Anaemia of pregnancy treated with total-dose infusion of iron-polymaltose complex, teferrol.
Topics: Anemia; Clinical Trials as Topic; Female; Ferric Compounds; Hematinics; Hemoglobins; Humans; Iron; Maltose; Polysaccharides; Pregnancy; Pregnancy Complications, Hematologic; Time Factors | 1976 |
37 other study(ies) available for acebutolol and Anemia
| Article | Year |
|---|---|
Efficiency of intravenous iron carboxymaltose in patients with iron-deficiency anemia due to heavy menstrual bleeding: a single-center experience.
Topics: Anemia; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferritins; Hemoglobins; Humans; Iron; Maltose; Menorrhagia; Transferrins | 2022 |
[A case of chronic enteropathy associated with SLCO2A1 gene diagnosed by capsule endoscopy and successfully treated by ferric carboxymaltose].
Topics: Anemia; Anemia, Iron-Deficiency; Capsule Endoscopy; Female; Ferric Compounds; Humans; Inflammatory Bowel Diseases; Iron; Maltose; Middle Aged; Organic Anion Transporters; Ulcer | 2022 |
Clinical, economical and safety impact of ferric carboxymaltose use in Patient Blood Management programme in Portuguese National Health Service hospitals.
Topics: Adult; Anemia; Anemia, Iron-Deficiency; Ferric Compounds; Hemoglobins; Hospitals; Humans; Iron; Maltose; Portugal; Retrospective Studies; State Medicine | 2022 |
Perioperative Tracking of Intravenous Iron in Patients Undergoing On-Pump Cardiac Surgery: A Prospective, Single-Center Pilot Trial.
Topics: Administration, Intravenous; Anemia; Cardiac Surgical Procedures; Female; Ferric Compounds; Humans; Iron; Male; Maltose; Pilot Projects; Prospective Studies | 2023 |
Ferric Carboxymaltose in the treatment of chemotherapy-induced anaemia: an effective, safe and cost- sparing alternative to blood transfusion.
Topics: Aged; Aged, 80 and over; Anemia; Antineoplastic Agents; Female; Ferric Compounds; Humans; Male; Maltose; Middle Aged; Neoplasms; Quality of Life; Retrospective Studies; Treatment Outcome | 2019 |
Preoperative Intravenous Iron and Erythropoietin to Treat Severe Anemia in Patient With Stage 4 Kidney Disease Before Oncologic Surgery: A Case Report.
Topics: Administration, Intravenous; Anemia; Endometrial Neoplasms; Erythropoietin; Female; Ferric Compounds; Hemoglobins; Humans; Hysterectomy; Infusions, Intravenous; Iron; Kidney Diseases; Maltose; Middle Aged; Preoperative Care; Severity of Illness Index; Trace Elements; Treatment Outcome | 2020 |
Comment on: Intravenous ferric carboxymaltose for iron deficiency anemia or iron deficiency without anemia after poor response to oral iron treatment: Benefits and risks in a cohort of 144 children and adolescents.
Topics: Administration, Intravenous; Adolescent; Anemia; Anemia, Iron-Deficiency; Child; Ferric Compounds; Humans; Iron; Maltose; Risk Assessment | 2021 |
Comparison of the maternal and neonatal outcomes of pregnant women whose anemia was not corrected before delivery and pregnant women who were treated with intravenous iron in the third trimester.
Topics: Adult; Anemia; Case-Control Studies; Cesarean Section; Female; Ferric Compounds; Gestational Age; Humans; Infant; Infant, Newborn; Infant, Small for Gestational Age; Injections, Intravenous; Iron; Maltose; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Outcome; Pregnancy Trimester, Third; Pregnant Women; Retrospective Studies; Turkey | 2021 |
"Camel humps"-shaped red blood cell histogram in a woman with extreme anemia treated with intravenous iron.
Topics: Aged; Anemia; Erythrocyte Volume; Erythrocytes, Abnormal; Female; Ferric Compounds; Gastrointestinal Hemorrhage; Hemoglobins; Hemorrhoids; Humans; Infusions, Intravenous; Leucovorin; Maltose; Rectum; Reticulocyte Count; Vitamin B 12 | 2021 |
Preoperative Intravenous Iron in Anemic Patients Undergoing Major Abdominal Surgery May Not PREVENTT Blood Transfusions But Still Contribute to the Objectives of Patient Blood Management.
Topics: Abdomen; Administration, Intravenous; Anemia; Biomarkers; Blood Loss, Surgical; Blood Transfusion; Drug Administration Schedule; Ferric Compounds; Hematinics; Hemoglobins; Humans; Maltose; Randomized Controlled Trials as Topic; Risk Factors; Treatment Outcome | 2021 |
Ferric carboxymaltose vs. ferrous sulfate for the treatment of anemia in advanced chronic kidney disease: an observational retrospective study and cost analysis.
Topics: Aged; Anemia; Costs and Cost Analysis; Darbepoetin alfa; Ferric Compounds; Ferrous Compounds; Hematologic Tests; Hemoglobins; Humans; Iron; Maltose; Renal Insufficiency, Chronic; Retrospective Studies; Time Factors; Treatment Outcome | 2021 |
Patient Blood Management in Major Orthopedic Surgery: Less Erythropoietin and More Iron?
Topics: Aged; Aged, 80 and over; Anemia; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Biomarkers; Blood Loss, Surgical; Blood Transfusion; Drug Administration Schedule; Drug Compounding; Erythropoietin; Female; Ferric Compounds; Hematinics; Hemoglobins; Humans; Infusions, Intravenous; Injections, Subcutaneous; Male; Maltose; Middle Aged; Program Evaluation; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2017 |
Therapy experiences and preferences among patients with anemia: Results of a cross-sectional survey among Italian patients with inflammatory bowel disease.
Topics: Absenteeism; Administration, Intravenous; Administration, Oral; Adult; Anemia; Caregivers; Cost of Illness; Cross-Sectional Studies; Employment; Female; Ferric Compounds; Health Care Surveys; Hemoglobins; Humans; Inflammatory Bowel Diseases; Iron; Male; Maltose; Middle Aged; Patient Preference; Severity of Illness Index | 2017 |
Ferric Carboxymaltose to Treat Isovolemic Anemia.
Topics: Anemia; Anemia, Iron-Deficiency; Ferric Compounds; Humans; Maltose | 2017 |
Ferric Carboxymaltose to Treat Isovolemic Anemia-Reply.
Topics: Anemia; Anemia, Iron-Deficiency; Ferric Compounds; Humans; Maltose | 2017 |
Clinical experience with ferric carboxymaltose in the management of anemia in acute gastrointestinal bleeding.
Topics: Aged; Aged, 80 and over; Anemia; Biomarkers; Blood Transfusion; Erythropoiesis; Female; Ferric Compounds; Gastrointestinal Hemorrhage; Hematinics; Hemoglobins; Humans; Infusions, Intravenous; Length of Stay; Male; Maltose; Middle Aged; Patient Admission; Retrospective Studies; Spain; Time Factors; Treatment Outcome | 2019 |
Anemia and iron deficiency in inflammatory bowel disease: an open, prospective, observational study on diagnosis, treatment with ferric carboxymaltose and quality of life.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anemia; Colitis, Ulcerative; Crohn Disease; Erythrocyte Indices; Female; Ferric Compounds; Ferritins; Guideline Adherence; Hematinics; Hemoglobins; Humans; Iron Deficiencies; Male; Maltose; Middle Aged; Practice Guidelines as Topic; Prospective Studies; Quality of Life; Sweden; Transferrin; Young Adult | 2013 |
The IRONMAN trial: a protocol for a multicentre randomised placebo-controlled trial of intravenous iron in intensive care unit patients with anaemia.
Topics: Anemia; Ferric Compounds; Maltose | 2015 |
Severe Acute Anemia After Liver Transplantation in an Elderly Jehovah's Witness Treated With High-dose Erythropoietin and Ferric Carboxymaltose: A Case Report.
Topics: Anemia; Blood Transfusion; Erythropoietin; Female; Ferric Compounds; Humans; Jehovah's Witnesses; Liver Transplantation; Maltose; Middle Aged; Reticulocyte Count; Shock, Hemorrhagic; Treatment Outcome; Treatment Refusal | 2015 |
Ferric carboxymaltose reduces transfusions and hospital stay in patients with colon cancer and anemia.
Topics: Aged; Anemia; Blood Transfusion; Colonic Neoplasms; Erythrocyte Indices; Female; Ferric Compounds; Hemoglobins; Humans; Iron; Length of Stay; Male; Maltose; Postoperative Complications; Transplantation, Homologous; Treatment Outcome | 2016 |
Implementing a blood management protocol during the entire perioperative period allows a reduction in transfusion rate in major orthopedic surgery: a before-after study.
Topics: Adult; Anemia; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Blood Transfusion; Controlled Before-After Studies; Erythropoietin; Female; Ferric Compounds; Humans; Male; Maltose; Orthopedic Procedures; Perioperative Period; Postoperative Period; Prospective Studies; Tranexamic Acid | 2016 |
Impact of a blood management protocol on transfusion rates and outcomes following total hip and knee arthroplasty.
Topics: Anemia; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Blood Transfusion; Clinical Protocols; Epoetin Alfa; Ferric Compounds; Ferritins; Hematinics; Hemoglobins; Hospitals, General; Humans; Length of Stay; Maltose; Patient Readmission; Postoperative Complications; Preoperative Care; Retrospective Studies; United Kingdom | 2016 |
Intravenous Iron Carboxymaltose as a Potential Therapeutic in Anemia of Inflammation.
Topics: Administration, Intravenous; Anemia; Animals; Biomarkers; Brucella abortus; Cytokines; Diet; Ferric Compounds; Hepcidins; Inflammation; Iron; Maltose; Mice; Reticulocytes; RNA, Messenger | 2016 |
Postoperative intravenous iron: a simple strategy to improve outcomes.
Topics: Anemia; Ferric Compounds; Humans; Iron; Maltose; Prospective Studies | 2016 |
Use of iron sucrose and red blood cell transfusions in anaemic cancer patients in France (OncoFer study).
Topics: Adult; Aged; Anemia; Erythrocyte Transfusion; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; France; Glucaric Acid; Hematologic Neoplasms; Hemoglobins; Humans; Male; Maltose; Middle Aged; Neoplasms; Retrospective Studies | 2017 |
Definition of functional iron deficiency and intravenous iron supplementation.
Topics: Anemia; Anemia, Iron-Deficiency; Dietary Supplements; Ferric Compounds; Humans; Iron; Maltose; Prospective Studies | 2016 |
Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial.
Topics: Anemia; Drug Approval; Female; Ferric Compounds; Heart Diseases; Hematinics; Humans; Infusions, Intravenous; Maltose; Puerperal Disorders; Randomized Controlled Trials as Topic; United States | 2008 |
Efficacy and safety of ferric carboxymaltose in correcting iron-deficiency anemia: a review of randomized controlled trials across different indications.
Topics: Anemia; Anemia, Iron-Deficiency; Breast Feeding; Female; Ferric Compounds; Ferritins; Heart Failure; Humans; Infant; Inflammatory Bowel Diseases; Maltose; Pilot Projects; Puerperal Disorders; Randomized Controlled Trials as Topic; Renal Insufficiency; Safety; Transferrin | 2010 |
A multicentre comparative study on the efficacy of intravenous ferric carboxymaltose and iron sucrose for correcting preoperative anaemia in patients undergoing major elective surgery.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Costs and Cost Analysis; Elective Surgical Procedures; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Male; Maltose; Middle Aged; Preoperative Care | 2011 |
Evaluation of cost savings with ferric carboxymaltose in anemia treatment through its impact on erythropoiesis-stimulating agents and blood transfusion: French healthcare payer perspective.
Topics: Anemia; Blood Transfusion; Cost Savings; Costs and Cost Analysis; Dose-Response Relationship, Drug; Erythropoiesis; Female; Ferric Compounds; France; Hematinics; Humans; Maltose; Models, Economic | 2012 |
Anaemia tolerance: bridging with intravenous ferric carboxymaltose in a patient with acute post-haemorrhagic anaemia.
Topics: Accidents, Traffic; Adolescent; Anemia; Erythrocyte Count; Ferric Compounds; Hemoglobins; Hemorrhage; Humans; Male; Maltose; Wounds and Injuries | 2012 |
Efficacy and toxicity of intravenous iron in a mouse model of critical care anemia*.
Topics: Anemia; Animals; Antimicrobial Cationic Peptides; Catalase; Diet; Disease Models, Animal; Ferric Compounds; Hematinics; Hemoglobins; Hepcidins; Inflammation; Injections, Intravenous; Iron; Liver; Luminescence; Maltose; Mice; Mice, Inbred C57BL; Phlebotomy; Random Allocation; Reactive Oxygen Species; RNA, Messenger; Sepsis; Spleen; Superoxide Dismutase; Trace Elements; Zymosan | 2012 |
Resurrecting the iron age*.
Topics: Anemia; Animals; Ferric Compounds; Hematinics; Maltose | 2012 |
Intravenous iron treatment in pregnancy: comparison of high-dose ferric carboxymaltose vs. iron sucrose.
Topics: Administration, Intravenous; Adolescent; Adult; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Maltose; Middle Aged; Pregnancy; Pregnancy Complications, Hematologic; Retrospective Studies; Young Adult | 2012 |
Experience with the use of an iron polymaltose (dextrin) complex given by single total dose infusion to stable chronic haemodialysis patients.
Topics: Adult; Anemia; Dextrins; Erythrocyte Indices; Female; Ferritins; Hemoglobins; Humans; Infusions, Intravenous; Iron; Kidney Failure, Chronic; Male; Maltose; Middle Aged; Renal Dialysis; Transferrin | 2002 |
[IRON THERAPY, USING INTRAMUSCULAR ADMINISTRATION. THERAPEUTIC TRIAL OF IRON-POLYMALTOSATE].
Topics: Anemia; Anemia, Hypochromic; Colonic Neoplasms; Deglutition Disorders; Female; Hernia, Diaphragmatic; Humans; Iron; Maltose; Metrorrhagia; Postoperative Complications; Stomach Neoplasms; Uterine Neoplasms | 1963 |
[EFFECTIVENESS OF THE NON-ORAL IRON DRUG, IRON-POLYMALTOSE, IN ANEMIA].
Topics: Anemia; Ferric Compounds; Humans; Iron; Maltose | 1963 |